Institutional Fund
Remedium Capital Partners, LLC
Fort Lauderdale, FLCIK 21045013 filings on record
Portfolio Value
$281.15M
Q1 2026
Holdings
6
Reported positions
New Buys
0
Opened this quarter
QoQ Change
+165077.4%
from $170.2K
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Oruka Therapeutics Inc27.3%
- Spyre Therapeutics Inc26.1%
- Galecto Inc18.8%
- Apogee Therapeutics Inc17.5%
- Jade Biosciences Inc7.9%
- Crescent Biopharma Inc.2.4%
Portfolio Holdings
6 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Oruka Therapeutics Inc | 1.57M | $76.80M | 27.3% | +13.2K | Added |
| 2 | Spyre Therapeutics Inc | 1.46M | $73.45M | 26.1% | 0 | Held |
| 3 | Galecto Inc | 2.05M | $52.98M | 18.8% | +1.93M | Added |
| 4 | Apogee Therapeutics Inc | 583.6K | $49.12M | 17.5% | 0 | Held |
| 5 | Jade Biosciences Inc | 1.58M | $22.17M | 7.9% | 0 | Held |
| 6 | Crescent Biopharma Inc. | 361.3K | $6.64M | 2.4% | 0 | Held |